Case Report
BibTex RIS Cite
Year 2020, Volume: 9 Issue: 3, 139 - 141, 21.12.2020
https://doi.org/10.47493/abantmedj.2020.23

Abstract

References

  • 1. Starkey E, Shahidullah H. Propranolol for infantile haemangiomas: a review. Arch Dis Child 2011; 96(9): 890-93.
  • 2. Yang H, Hu DL, Shu Q, Guo XD. Efficacy and adverse effects of oral propranolol in infantile hemangioma: a meta-analysis of comparative studies. World J Pediatr 2019; 15: 546–58.
  • 3. Kim J, Hong JW, Roh TS, Lee WJ. Oral propranolol therapy in 23 infants with infantile hemangioma. Arch Plast Surg 2018;45(6): 517-24.
  • 4. Léauté-Labrèze C, Harper JI, Hoeger PH. Infantile haemangioma. Lancet 2017; 390 (10089): 85–94.
  • 5. Chinnadurai S, Sathe NA, Surawicz T. Laser treatment of infantile hemangioma: A systematic review. Lasers Surg Med. 2016; 48(3): 221–33.
  • 6. Ng M, Knuth C, Weisbrod C, Murthy A. Propranolol therapy for problematic infantile hemangioma. Ann Plast Surg 2016; 76 (3): 306-10.
  • 7. Wang C, Li Y, Xiang B, Xiong F, Li K, Yang K, Chen S, Ji Y. Quality of life in children with infantile hemangioma: a case control study. Health Qual Life Outcomes 2017; 15(1): 221.
  • 8. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taieb A. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649-51.
  • 9. Greenberger S, Bischoff J. Pathogenesis of infantile haemangioma. Brit J Dermatol 2013; 169: 12-9.
  • 10. Aslan N, Arıkan E, Sivrice C, Ayata A. Propranolol ile Tedavi Edilen İnfantil Hemanjiyom: Bir Olgu Sunumu. Türkiye Çocuk Hast Derg 2015; 4: 278-279.

İnfantil Hemanjiomda Propranolol Tedavisi: Bir olgu sunumu

Year 2020, Volume: 9 Issue: 3, 139 - 141, 21.12.2020
https://doi.org/10.47493/abantmedj.2020.23

Abstract

İnfantil hemanjiom bebeklik döneminin en sık görülen vasküler selim tümörüdür. İnfantil hemanjiomun tedavisinde steroidler yıllardır ilk tercih olmakla birlikte son yıllarda oral propranolol de kullanılmaya başlanmıştır. Bu olgu ile eksremitelerinde hızlı büyüyen infantil hemanjiomu olan 1 aylık kız hastada birinci basamak tedavi olarak oral propranolol kullanımı sunulmuştur.

References

  • 1. Starkey E, Shahidullah H. Propranolol for infantile haemangiomas: a review. Arch Dis Child 2011; 96(9): 890-93.
  • 2. Yang H, Hu DL, Shu Q, Guo XD. Efficacy and adverse effects of oral propranolol in infantile hemangioma: a meta-analysis of comparative studies. World J Pediatr 2019; 15: 546–58.
  • 3. Kim J, Hong JW, Roh TS, Lee WJ. Oral propranolol therapy in 23 infants with infantile hemangioma. Arch Plast Surg 2018;45(6): 517-24.
  • 4. Léauté-Labrèze C, Harper JI, Hoeger PH. Infantile haemangioma. Lancet 2017; 390 (10089): 85–94.
  • 5. Chinnadurai S, Sathe NA, Surawicz T. Laser treatment of infantile hemangioma: A systematic review. Lasers Surg Med. 2016; 48(3): 221–33.
  • 6. Ng M, Knuth C, Weisbrod C, Murthy A. Propranolol therapy for problematic infantile hemangioma. Ann Plast Surg 2016; 76 (3): 306-10.
  • 7. Wang C, Li Y, Xiang B, Xiong F, Li K, Yang K, Chen S, Ji Y. Quality of life in children with infantile hemangioma: a case control study. Health Qual Life Outcomes 2017; 15(1): 221.
  • 8. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taieb A. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649-51.
  • 9. Greenberger S, Bischoff J. Pathogenesis of infantile haemangioma. Brit J Dermatol 2013; 169: 12-9.
  • 10. Aslan N, Arıkan E, Sivrice C, Ayata A. Propranolol ile Tedavi Edilen İnfantil Hemanjiyom: Bir Olgu Sunumu. Türkiye Çocuk Hast Derg 2015; 4: 278-279.
There are 10 citations in total.

Details

Primary Language Turkish
Subjects Clinical Sciences
Journal Section Case Report
Authors

Hatice Tuba Akbayram 0000-0002-9777-9596

Ayse Ören This is me 0000-0001-5063-2098

Publication Date December 21, 2020
Submission Date April 20, 2020
Published in Issue Year 2020 Volume: 9 Issue: 3

Cite

APA Akbayram, H. T., & Ören, A. (2020). İnfantil Hemanjiomda Propranolol Tedavisi: Bir olgu sunumu. Abant Medical Journal, 9(3), 139-141. https://doi.org/10.47493/abantmedj.2020.23
AMA Akbayram HT, Ören A. İnfantil Hemanjiomda Propranolol Tedavisi: Bir olgu sunumu. Abant Med J. December 2020;9(3):139-141. doi:10.47493/abantmedj.2020.23
Chicago Akbayram, Hatice Tuba, and Ayse Ören. “İnfantil Hemanjiomda Propranolol Tedavisi: Bir Olgu Sunumu”. Abant Medical Journal 9, no. 3 (December 2020): 139-41. https://doi.org/10.47493/abantmedj.2020.23.
EndNote Akbayram HT, Ören A (December 1, 2020) İnfantil Hemanjiomda Propranolol Tedavisi: Bir olgu sunumu. Abant Medical Journal 9 3 139–141.
IEEE H. T. Akbayram and A. Ören, “İnfantil Hemanjiomda Propranolol Tedavisi: Bir olgu sunumu”, Abant Med J, vol. 9, no. 3, pp. 139–141, 2020, doi: 10.47493/abantmedj.2020.23.
ISNAD Akbayram, Hatice Tuba - Ören, Ayse. “İnfantil Hemanjiomda Propranolol Tedavisi: Bir Olgu Sunumu”. Abant Medical Journal 9/3 (December 2020), 139-141. https://doi.org/10.47493/abantmedj.2020.23.
JAMA Akbayram HT, Ören A. İnfantil Hemanjiomda Propranolol Tedavisi: Bir olgu sunumu. Abant Med J. 2020;9:139–141.
MLA Akbayram, Hatice Tuba and Ayse Ören. “İnfantil Hemanjiomda Propranolol Tedavisi: Bir Olgu Sunumu”. Abant Medical Journal, vol. 9, no. 3, 2020, pp. 139-41, doi:10.47493/abantmedj.2020.23.
Vancouver Akbayram HT, Ören A. İnfantil Hemanjiomda Propranolol Tedavisi: Bir olgu sunumu. Abant Med J. 2020;9(3):139-41.